CAR T-Cell Therapy in Multiple Myeloma : Episode 4
CAR-T Therapy Journey: From Cell Collection to Managing Challenges
Panelists discuss the chimeric antigen receptor (CAR) T-cell collection, manufacturing, and infusion process, highlighting how it differs from previous treatments, and share the challenges faced during CAR T-cell therapy, including managing adverse effects.
Video content above is prompted by the following:
- Could you describe your experience with the chimeric antigen receptor (CAR) T-cell collection, manufacturing, and infusion process? How did this differ from your previous lines of treatment?
- What challenges did you face during CAR T-cell therapy, and how did you manage adverse effects?
Recent Videos
Related Content
